Hospice News October 21, 2025
The acquisition of the home health and hospice provider Amedisys by the insurance mammoth UnitedHealth Group (NYSE: UNH) has far-reaching implications for the hospice community.
The UnitedHealth Group subsidiary Optum, in June 2023 inked its agreement to acquire Amedisys in an all-cash transaction of $101 per share, or about $3.3 billion. After leaping a series of regulatory hurdles, including a U.S. Justice Department lawsuit, the deal closed in mid-August.
The acquisition shines a spotlight on the growing importance of home-based care in the continuum, but could accelerate consolidation in the space, according to James Dismond, CEO of MiraSol Health.
“The UnitedHealth Group–Amedisys transaction represents a structural moment for the entire hospice industry, one that is likely to accelerate vertical integration...







